{"id":3914,"date":"2024-04-29T18:45:26","date_gmt":"2024-04-29T18:45:26","guid":{"rendered":"https:\/\/sygeplejevidenskab.dk\/?p=3914"},"modified":"2026-05-07T18:50:08","modified_gmt":"2026-05-07T16:50:08","slug":"kan-mundskyl-med-hvid-te-forebygge-oral-mucositis-hos-patienter-med-brystkraeft","status":"publish","type":"post","link":"https:\/\/sygeplejevidenskab.dk\/index.php\/2024\/04\/29\/kan-mundskyl-med-hvid-te-forebygge-oral-mucositis-hos-patienter-med-brystkraeft\/","title":{"rendered":"Kan mundskyl med hvid te forebygge oral mucositis hos patienter med brystkr\u00e6ft?"},"content":{"rendered":"
\n

\"\"<\/p>\n

Agnete Kaltoft <\/span>1 <\/span><\/strong>Anne Meyling Godskesen <\/span>2 <\/span><\/strong>Signe Timm <\/span>3 <\/span><\/strong>Cathrine Lundgaard Riis <\/span>4 <\/span><\/strong>Mette Stie <\/span>5<\/span><\/strong><\/p>\n

1 <\/span><\/strong>Klinisk sygeplejespecialist cand. scient. san., Onkologisk Afdeling, Sygehus Lilleb\u00e6lt
\n<\/span>2<\/span><\/strong> Oversygeplejerske, Onkologisk Afdeling, Sygehus Lilleb\u00e6lt
\n<\/span>3<\/span><\/strong> Specialkonsulent i epidemiologi og biostatistik, Cand.scient.san.publ, ph.d., Onkologisk forskningsenhed (KFE), Vejle Sygehus
\n<\/span>4 <\/span><\/strong>Speciall\u00e6ge i Onkologi, Phd., Onkologisk Afdeling, Sygehus Lilleb\u00e6lt
\n<\/span>5<\/span><\/strong> Klinisk sygeplejespecialist, Post.doc., cand.cur., Phd., Onkologisk Afdeling, Sygehus Lilleb\u00e6lt<\/span><\/p>\n

\n

Resum\u00e9
\n<\/span><\/strong>Baggrund
\n<\/span><\/strong>Mundgener er en kendt bivirkning til kemoterapi med beskadigelse af mundslimhinden. Oral mucositis kan blandt andet for\u00e5rsage \u00f8m mund, mundt\u00f8rhed, smerter, smagsforandringer, bl\u00f8dning og infektion, som kan f\u00f8re til nedsat f\u00f8deindtag og dermed p\u00e5virke patientens ern\u00e6ringstilstand og velv\u00e6re.
\n<\/span>Form\u00e5l
\n<\/span><\/strong>Form\u00e5let var at unders\u00f8ge, om hvid te i h\u00f8jere grad forebygger mucositis end standard mundpleje med skylning med salt\/natron hos patienter.
\n<\/span>Design
\n<\/span><\/strong>Studiet blev gennemf\u00f8rt som et randomiseret kontrolleret interventionsstudie i Onkologisk Ambulatorium, Sygehus Lilleb\u00e6lt.
\n<\/span>Metode
\n<\/span><\/strong>Otteogfirs patienter i kemoterapibehandling med paclitaxel for brystkr\u00e6ft blev inkluderet i perioden august 2020 til marts 2023. I interventionsgruppen deltog 44 patienter og i kontrolgruppen deltog 44 patienter. Data blev analyseret med kvantitativ analyse.
\n<\/span>Resultater
\n<\/span><\/strong>Studiet viste, at der ikke var forskel mellem deltagerne, der skyllede munden med hvid te sammenlignet med dem, der anvendte salt\/natron. Smertescoren i mundhulen for b\u00e5de interventions- og kontrolgruppen forblev \u2264 3 fra baseline og frem til 9. followup.
\n<\/span>Konklusion
\n<\/span><\/strong>Der er ikke forskel mellem brug af hvid te og standard mundpleje med salt\/natron til forebyggelse af oral mucositis og smerte i mundhulen hos kvinder i behandling for brystkr\u00e6ft med paclitaxel.<\/span> Yderligere forskning er n\u00f8dvendig for at identificere effektive metoder til at forbygge oral mucositis.<\/span><\/p>\n

English abstract<\/h5>\n

<\/h4>\n

Can mouth rinses with white tea prevent oral mucositis in patients with breast cancer?<\/h4>\n

Background<\/strong>
\nOral discomfort is a well\u2011known side effect of chemotherapy due to damage to the oral mucosa. Oral mucositis may cause a sore mouth, dry mouth, pain, taste changes, bleeding and infection, which can lead to reduced food intake and thereby affect patients\u2019 nutritional status and well\u2011being.
\nAim<\/strong>
\nThe aim was to investigate whether white tea is more effective than standard oral care with saline\/bicarbonate rinses in preventing oral mucositis in patients receiving chemotherapy.
\nDesign<\/strong>
\nThe study was conducted as a randomised controlled intervention trial in the Oncology Outpatient Clinic at Sygehus Lilleb\u00e6lt.
\nMethod<\/strong>
\nEighty\u2011eight patients receiving paclitaxel chemotherapy for breast cancer were included between August 2020 and March 2023. The intervention group comprised 44 patients and the control group 44 patients. Data were analysed using quantitative methods.
\nResults<\/strong>
\nThe study showed no difference between participants who rinsed their mouths with white tea and those who used saline\/bicarbonate. The oral pain score for both the intervention and control groups remained \u2264 3 from baseline through the ninth follow\u2011up.
\nConclusion<\/strong>
\nThere was no difference between white tea and standard oral care with saline\/bicarbonate in preventing oral mucositis and oral pain in women receiving paclitaxel for breast cancer. Further research is needed to identify effective methods for preventing oral mucositis.<\/p>\n

Keywords:<\/strong> Oral mucositis, white tea, breast cancer, paclitaxel, chemotherapy side effects, randomised controlled trial.<\/p>\n<\/div>\n<\/div>\n

\n
\n
\n
\n
\n

Vil du l\u00e6se videre?
\nF\u00e5 adgang til artiklen med:<\/h2>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n
\n
\n\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\tPLUSmedlem<\/span>
\n\t\t\t\t\t<\/span>
\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n

Enkelt k\u00f8b af artikel<\/h2>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n
\n<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n
\n
\n
\n